Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.3B | 8.1B | 11.7B | 10.4B |
Cost of revenue | 6.6B | 6.6B | 9.2B | 7.9B |
Gross profit | 1.7B | 1.4B | 2.5B | 2.4B |
Operating expense | ||||
Research & development | 559.1M | 513.0M | 610.1M | 635.5M |
Selling general and admin | -38.4M | 376.5M | -326.6M | 831.2M |
Other operating expenses | 63.6M | 52.8M | 108.0M | 51.0M |
Operating income | 787.7M | 531.9M | 1.4B | 1.4B |
Non operating interest income | ||||
Income | 119.5M | 120.6M | 114.0M | 105.8M |
Expense | -28.0M | 29.1M | -79.3M | 80.7M |
Other income expense | — | — | — | — |
Pretax income | 893.3M | 570.0M | 1.9B | 1.3B |
Tax provision | 153.5M | 83.6M | 276.2M | 121.7M |
Net income | 739.8M | 486.3M | 1.6B | 1.2B |
Basic EPS | — | 0.2 | — | — |
Diluted EPS | — | 0.2 | — | — |
Basic average shares | — | 2.3B | — | — |
Diluted average shares | — | 2.3B | — | — |
EBITDA | 839.4M | 676.1M | 1.8B | 1.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 5.0M | 1.8M | 928.8K | 264.9K |
Preferred stock dividends | 0 | 0 | 0 | 0 |